Quinapril (Preferred Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Quinapril drug offered from Preferred Pharmaceuticals Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Preferred Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | Quinapril Hydrochloride |
SUBSTANCE NAME: | QUINAPRIL HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-02-13 |
END MARKETING DATE: | 0000-00-00 |
Quinapril HUMAN PRESCRIPTION DRUG Details:
Item Description | Quinapril from Preferred Pharmaceuticals Inc. |
LABELER NAME: | Preferred Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 2017-02-13 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68788-6894_ace9eae8-5336-4c40-b8ce-105e2238a49a |
PRODUCT NDC: | 68788-6894 |
APPLICATION NUMBER: | ANDA202725 |
Other QUINAPRIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: